Saratoga Research & Investment Management Cuts Stake in Johnson & Johnson Amid Strong Q2 Results

Saratoga Research & Investment Management has reduced its stake in Johnson & Johnson by 18% in the second quarter, selling 60,982 shares. The institutional investor now owns 278,459 shares of the company's stock, making up 3.9% of its holdings and ranking Johnson & Johnson as its 10th largest holding. According to its most recent SEC filing, Saratoga Research & Investment Management's holdings in Johnson & Johnson are worth $70,720,000.

Johnson & Johnson's second-quarter revenue rose by 6.6% year over year, reaching $25.31 billion. The company also reported adjusted EPS of $2.90, exceeding the $2.84 consensus estimate and beating expectations in both categories. Johnson & Johnson has raised its FY 2026 guidance to a range of 11.600-11.750 EPS.

The business recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 25th will receive $1.34 per share, representing a yield of 2.0% and an annualized dividend payout ratio of 62.11%. The ex-dividend date is set for Tuesday, August 25th.